BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16971038)

  • 21. [Locally recurrent prostatic adenocarcinoma after exclusive radiotherapy: results of high intensity focused ultrasound].
    Poissonnier L; Murat FJ; Belot A; Bouvier R; Rabilloud M; Rouviere O; Chapelon JY; Gelet A
    Prog Urol; 2008 Apr; 18(4):223-9. PubMed ID: 18501302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histopathological findings after treatment of prostate cancer using high-intensity focused ultrasound (HIFU).
    Biermann K; Montironi R; Lopez-Beltran A; Zhang S; Cheng L
    Prostate; 2010 Aug; 70(11):1196-200. PubMed ID: 20564422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of neoadjuvant androgen suppression on prostate cancer-related outcomes after high-intensity focused ultrasound therapy.
    Uchida T; Illing RO; Cathcart PJ; Emberton M
    BJU Int; 2006 Oct; 98(4):770-2. PubMed ID: 16879448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-intensity focused ultrasound and cryotherapy as salvage treatment in local radio-recurrent prostate cancer.
    Autran-Gomez AM; Scarpa RM; Chin J
    Urol Int; 2012; 89(4):373-9. PubMed ID: 22797110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Energy-based ablative therapy of prostate cancer: high-intensity focused ultrasound and cryoablation.
    Marberger M
    Curr Opin Urol; 2007 May; 17(3):194-9. PubMed ID: 17414518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer.
    Muto S; Yoshii T; Saito K; Kamiyama Y; Ide H; Horie S
    Jpn J Clin Oncol; 2008 Mar; 38(3):192-9. PubMed ID: 18281309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transrectal high-intensity focused ultrasound for local treatment of prostate cancer: current role.
    Chaussy CG; Thüroff S
    Arch Esp Urol; 2011 Jul; 64(6):493-506. PubMed ID: 21791716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of color Doppler in guiding prostate biopsy after HIFU ablation.
    Rouvière O; Mège-Lechevallier F; Chapelon JY; Gelet A; Bouvier R; Boutitie F; Lyonnet D
    Eur Urol; 2006 Sep; 50(3):490-7. PubMed ID: 16439055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transurethral resection of the prostate immediately after high-intensity focused ultrasound treatment for prostate cancer.
    Sumitomo M; Asakuma J; Sato A; Ito K; Nagakura K; Asano T
    Int J Urol; 2010 Nov; 17(11):924-30. PubMed ID: 20969640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [High-intensity focused ultrasound for localized prostate cancer].
    Uchida T
    Nihon Rinsho; 2005 Feb; 63(2):345-9. PubMed ID: 15714990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors predicting for formation of bladder outlet obstruction after high-intensity focused ultrasound in treatment of localized prostate cancer.
    Blana A; Hierl J; Rogenhofer S; Lunz JC; Wieland WF; Walter B; Bach T; Ganzer R
    Urology; 2008 May; 71(5):863-7. PubMed ID: 18313119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [High intensity focused ultrasound in localized prostate cancer].
    Coulange C
    Cancer Radiother; 2005 Nov; 9(6-7):377-8. PubMed ID: 16168696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sonablate-500: transrectal high-intensity focused ultrasound for the treatment of prostate cancer.
    Illing R; Emberton M
    Expert Rev Med Devices; 2006 Nov; 3(6):717-29. PubMed ID: 17280536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histological changes in prostate biopsies after salvage cryotherapy: effect of chronology and the method of biopsy.
    Izawa JI; Busby JE; Morganstern N; Vakar-Lopez F; Scott SM; Pisters LL
    BJU Int; 2006 Sep; 98(3):554-8. PubMed ID: 16925753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visually directed transrectal high intensity focused ultrasound for the treatment of prostate cancer: a preliminary report on the Italian experience.
    Mearini L; D'Urso L; Collura D; Zucchi A; Costantini E; Formiconi A; Bini V; Muto G; Porena M
    J Urol; 2009 Jan; 181(1):105-11; discussion 111-2. PubMed ID: 19081465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Technology review: high-intensity focused ultrasound for prostate cancer.
    Pickles T; Goldenberg L; Steinhoff G
    Can J Urol; 2005 Apr; 12(2):2593-7. PubMed ID: 15877941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Technology insight: High-intensity focused ultrasound for urologic cancers.
    Chaussy C; Thüroff S; Rebillard X; Gelet A
    Nat Clin Pract Urol; 2005 Apr; 2(4):191-8. PubMed ID: 16474762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy.
    Pisters LL; Leibovici D; Blute M; Zincke H; Sebo TJ; Slezak JM; Izawa J; Ward JF; Scott SM; Madsen L; Spiess PE; Leibovich BC
    J Urol; 2009 Aug; 182(2):517-25; discussion 525-7. PubMed ID: 19524984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry.
    Jones JS; Rewcastle JC; Donnelly BJ; Lugnani FM; Pisters LL; Katz AE
    J Urol; 2008 Aug; 180(2):554-8. PubMed ID: 18550117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology.
    Polascik TJ; Nosnik I; Mayes JM; Mouraviev V
    Urology; 2007 Jul; 70(1):117-21. PubMed ID: 17656220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.